Brixadi Side Effects and Management Strategies

Brixadi is an extended release subcutaneous injection that is used as part of the treatment plan of moderate to severe opioid use disorder (OUD) alongside counseling and behavioral therapy. The active ingredient is buprenorphine, which acts to prevent opioid withdrawal symptoms and mitigate craving. That said, Brixadi, like any medication on the market, comes with a ... Read more
Brixadi
Apr 3, 2024